A Randomized, Double‐Blind, Placebo‐Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP‐825) in the Treatment of Acute Migraine (The TARGET Study)

Publisher： John Wiley & Sons Inc

E-ISSN： 1526-4610|55|1|88-100

ISSN： 0017-8748

Source： HEADACHE, Vol.55, Iss.1, 2015-01, pp. : 88-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AVP‐825 Breath‐Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks

By  

HEADACHE, Vol. 55, Iss. 5, 2015-05 ,pp. : 621-635

John Wiley & Sons Inc

Access to resources Recommend Favorite

Greater occipital nerve blockade for the treatment of chronic migraine: a randomized, multicenter, double‐blind, and placebo‐controlled study

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 132, Iss. 4, 2015-10 ,pp. : 270-277

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Double‐Blind, Placebo‐Controlled Study of Repetitive Transnasal Sphenopalatine Ganglion Blockade With Tx360® as Acute Treatment for Chronic Migraine

By  

HEADACHE, Vol. 55, Iss. 1, 2015-01 ,pp. : 101-116

John Wiley & Sons Inc

Access to resources Recommend Favorite

Consistency of Response to Sumatriptan/Naproxen Sodium in a Randomized Placebo‐Controlled, Cross‐Over Study for the Acute Treatment of Migraine in Adolescence

By  

HEADACHE, Vol. 55, Iss. 4, 2015-04 ,pp. : 519-528

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg

By Diener Hans-Christoph  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1603-1610

Informa Healthcare

Access to resources Recommend Favorite